Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Inte:Ligand

The discovery of suitable lead structures for new drugs from an inexhaustibly large reservoir of theoretically possible compounds (order of magnitude: 10100) is one of the biggest challenges for the pharmaceutical industry. The search for the "needle in the haystack" (a drug candidate) nowadays is often performed by using high throughput screening (HTS), neglecting that even high-throughput methods can only cover an extremely small fraction of all possibilities. Inte:Ligand has developed methods to create new drug candidates and assess their development risks in a rational way.


Contact Details:
Mariahilferstrasse 74B/11
Vienna
1070
Austria
Tel:
Fax:
Email:office@inteligand.com.
WWW:

www.inteligand.com/




Recent Publications by Inte:Ligand:

How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information.
Shape-based molecular similarity approaches have been established as...
20th February, 2009
Department of Pharmaceutical Chemistry, Faculty of Chemistry and Pharmacy J Chem Inf Model. 2009 Feb 18.
DOI Direct Link
Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
Three-dimensional (3D) pharmacophore modeling is a technique for...
5th June, 2008
Inte:Ligand GmbH, Mariahilferstrasse 74B/11, 1070 Vienna, Austria. Drug Discov Today. 2008 Jan;13(1-2):23-9. Epub 2007 Nov 5.
DOI Direct Link
Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?
Within the last few years a considerable amount of evaluative studies has...
31st May, 2008
Inte:Ligand Software-Entwicklungs- und Consulting GmbH, Clemens Maria J Comput Aided Mol Des. 2008 Mar-Apr;22(3-4):213-28. Epub 2008 Jan 15.
DOI Direct Link
Efficient overlay of small organic molecules using 3D pharmacophores.
Aligning and overlaying two or more bio-active molecules is one of the key...
4th May, 2007
Inte:Ligand Softwareentwickungs- und Consulting GmbH, Mariahilferstrasse J Comput Aided Mol Des. 2006 Dec;20(12):773-88. Epub 2006 Oct 19.
DOI Direct Link
High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening.
In order to assess bioactivity profiles for small organic molecules we...
4th May, 2007
Inte:Ligand GmbH, Clemens Maria Hofbauer-Gasse 6, 2344 Maria Enzersdorf, J Comput Aided Mol Des. 2006 Dec;20(12):703-15. Epub 2006 Sep 29.
DOI Direct Link

View more Inte:Ligand research publications.

Press Releases on Inte:Ligand:

BioPortfolio Logo
TargetEx Leads the European Cancer Research Consortium 9th October, 2009
BUDAPEST, Hungary, October 9 /PRNewswire/ -- TargetEx llc, Budapest announced today that the Research Directorate General of the Commission of the European Communities approved the transfer of the

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 465 times since April 2007, the link to the organisation's website has been followed 120 times

Recent Search Terms used to find this page: inte | Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection | inte ligand | inte li | inteligand | inte-ligand | inteligand | pharmacophores from 2009 | .

Search for more companies in Vienna

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Inte:Ligand

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.